Metabolic Outcomes, Bone Health, and Risk of Polycystic Ovary Syndrome in Girls with Idiopathic Central Precocious Puberty Treated with Gonadotropin-Releasing Hormone Analogues

Maria Felicia Faienza,Giacomina Brunetti,Angelo Acquafredda,Maurizio Delvecchio,Antonella Lonero,Alberto Gaeta,Paola Suavo Bulzis,Domenico Corica,Maria Rosa Velletri,Filippo De Luca,Luciano Cavallo,Malgorzata Wasniewska

Metabolic Outcomes, Bone Health, and Risk of Polycystic Ovary Syndrome in Girls with Idiopathic Central Precocious Puberty Treated with Gonadotropin-Releasing Hormone Analogues

2017

Maria Felicia Faienza
Giacomina Brunetti
Angelo Acquafredda
Maurizio Delvecchio
Antonella Lonero
Alberto Gaeta
Paola Suavo Bulzis
Domenico Corica
Maria Rosa Velletri
Filippo De Luca
Luciano Cavallo
Malgorzata Wasniewska

Background/Aims: Gonadotropin-releasing hormone analogues (GnRHa) represent the gold standard treatment for central precocious puberty (CPP). We aimed to assess t

Keywords:

Internal medicine
Bone health
Hormone
Insulin resistance
Endocrinology
Diabetes mellitus
Gonadotropin-releasing hormone
Medicine
Ovary
Central precocious puberty
Idiopathic central precocious puberty
polycystic ovary

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations